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Available online 26 January 2016Background: Ovarian cancer remains one of the leading causes of cancer-related deaths among women. Clear
cell ovarian carcinoma is a rare histologic subtype accounting for 5–10% of all epithelial ovarian cancers and is
often associated with endometriosis. Patients generally present with vague abdominal and pelvic complaints.
However, patients can present in the acute setting with pleural effusions, ascites, bowel obstructions, and deep
vein thrombosis.
Case: A 54 year oldwoman presentingwith an acute abdomen secondary to rupture of ovarian clear cell carcinoma.
Conclusion: Ovarian clear cell carcinoma should remain in the differential diagnosis in a patient presenting with an
acute abdomen and imaging suspicious for a gynecologic malignancy originating from the ovary.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Despite advances in research, diagnosis, and treatment, ovarian
cancer remains the deadliest cancer of the female reproductive tract.
According to the American Cancer Society, approximately 21,000
women are diagnosed with ovarian cancer in the United States and
14,000 women will succumb to this disease annually. Clear cell ovarian
carcinoma, a histologic subtype of epithelial ovarian carcinoma,
accounts for approximately 5–10% of ovarian cancers. Women with
ovarian clear cell carcinoma, similar to the other ovarian epithelial
carcinomas, often present with vague pelvic and abdominal signs and
symptoms, such as bloating, early satiety, abdominal pain and disten-
tion, constipation, and changes in urinary habits. Acutely, patients may
present with pleural effusions, ascites, small bowel obstructions, or
deep vein thrombosis (Lim et al., 2009; Tan and Kaye, 2007). Here
we present the ﬁrst documented case of a ruptured ovarian clear cell
carcinoma presenting as an acute abdomen.
2. Case
The patient is a 54 year old G1P1001, postmenopausal woman who
presented to the emergency department complaining of severe abdom-
inal pain for the past 24 h. She reported that the pain was diffuse and2, New York, NY 10065, United
. This is an open access article underconstant; review of systemswas otherwise negative. Past gynecological
historywas remarkable for endometriosis. Pastmedical, surgical, family,
and social histories were non-contributory. On presentation, her vital
signswere remarkable for tachycardiawith a pulse of 105. The remainder
of her vital signs was within normal limits. On physical exam, her abdo-
men was distended, diffusely tender, dull to percussion, and positive for
both rebound and guarding. Her pelvic examwas remarkable for cervical
motion tenderness and diffuse tenderness. A palpable mass was appreci-
ated on the abdominal and rectovaginal exam. Lab work was signiﬁcant
for leukocytosis with a WBC count of 38.0 as well as an elevated lactate
of 3.6. An abdominal X-ray was negative for free air. Computed tomogra-
phy (CT) scan demonstrated a 15.5 × 16.6 × 18.2 cm heterogeneous
pelvic mass worrisome for malignancy, possibly ovarian (Fig. 1A-C).
Ascites was present, but no evidence of small bowel obstruction was
noted (Fig. 1A-C). The liver, spleen, pancreas, and appendix appeared
normal (Fig. 1A-C).
As the patient had an acute abdomen, the recommendation was
made by gynecologic oncology for immediate surgical intervention by
exploratory laparotomy. Exploration of the abdominal cavity revealed
hemoperitoneum, a ruptured large left adnexal mass adherent to the
posterior aspect of the uterus, which was surrounded by dark brown
ascites and actively extravasating bright red blood. At the base of the
lesion, a 6 cm fungating mass was noted. The ovarian capsule was
densely adherent to the mesentery of the small bowel and transverse
colon, which was surgically separated without incident. The uterus
and right fallopian tube and ovary appeared normal. There was no
obvious bowel or omental disease. A full staging procedure was not
performed because the patient was noted to have a large amount ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Post contrast enhanced CT images demonstrating a large heterogenous mass (PM) occupying the majority of the pelvis. The pelvic mass can be seen compressing the uterus (Ut).
Enhancing nodularity is noted in thepelvicmass,which is suspicious formalignancy. Small pelvic ascites is noted (Asc). Several subcentimeter retroperitoneal lymphnodes are noted (LN).
A, Axial view. B, Coronal view. C, Sagittal view.
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extravasating upon initial entry into the abdomen with an estimated
blood loss of approximately 500 cc. Only a systematic examination of
the pelvis and para-aortic regions was performed. A small mobile
enlarged para-aortic lymph nodewas palpated and excised. The patient
ultimately underwent an exploratory laparotomy, total abdominal
hysterectomy, bilateral salpingo-oophoretomy, excision of the pelvic
mass, omentectomy, and para-aortic lymph node dissection. An intra-
operative frozen section of the pelvic mass was performed and was
positive for ovarian carcinoma.
Final pathology returned as moderately differentiated clear cell
carcinoma of the ovary limited to the left ovary with ovarian surface
involvement (Fig. 2A-C). The immunohistological features of the
tumor including hyalinized papillary architecture lined by cytologically
atypical cells with clear cytoplasm with lack of immunohistochemical
evidence of p53 mutation or estrogen receptor (ER) expression, are
typical of clear cell carcinoma (Fig. 2B-C). The uterus, cervix, contralat-
eral fallopian tube and ovary, omentum, and para-aortic lymph nodes
were negative for carcinoma. Incidentally, endometriosis was noted
on the ovaries bilaterally (Fig. 2D). The patient's post-operative course
was uncomplicated; she was discharged home on post-operative
day 4. The patient's case was discussed at our multidisciplinary
tumor board and the recommendation is for her to be treated with a
6-course regimen of systemic adjuvant chemotherapy with carboplatin
and paclitaxel.3. Discussion
Ovarian cancer remains the ﬁfth leading cause of cancer related
death among women in the United States according to the National
Cancer Institute. Clear cell ovarian cancer is a rare histological subtype
of epithelial ovarian carcinomas that commonly presents in the
perimenopausal period and comprises a larger proportion of ovarian
cancers in the Asian population (del Carmen et al., 2012).When discov-
ered at an early stage, clear cell carcinoma of the ovary is associated
with a relatively good prognosis (del Carmen et al., 2012; Miyamoto
et al., 2013). However, advanced stage disease is often associated with
worse outcomes because of increased resistance to platinum-based
chemotherapywhen compared to other histologic subtypes of epithelial
ovarian cancer (Tan and Kaye, 2007; Miyamoto et al., 2013). Although
ovarian cancer generally presents with nonspeciﬁc abdominal symp-
toms or even as an incidental ﬁnding on imaging, previous reports
have documented cases of an acute abdomen secondary to spontaneous
rupture of ovarian granulosa cell tumors and ovarian adenocarcinoma
of mesonephrotic origin, respectively (Oge et al., 2012; Bastu et al.,
2013; Temelkov and Paskalev, 1976). To our knowledge, this is the
ﬁrst documented case of rupture of an ovarian clear cell carcinoma
presenting as an acute abdomen.
Based on the ﬁnal pathology, the patient was diagnosed with Stage
IC2 clear cell carcinoma of the ovary secondary to spontaneous rupture
of the tumor capsule. In a recent retrospective single-institution cohort
Fig. 2. Photomicrographs of left ovarian clear cell carcinoma (A–C) and right ovarian endometriosis (D). Prominent hyalinized stroma is often seen in clear cell ovarian carcinomas.
Neoplastic cells are noted to have distinct cell borders and a wide range of nuclear and cytologic atypia. A, 400× H&E. B, 400× p53 immunohistochemistry (negative). C, 400×
estrogen receptor immunohistochemistry (negative). D, 400× H&E.
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presentedwith Stage I disease at the time of diagnosis. Of these patients,
45.5% of patients were diagnosed with Stage IC disease, which was
deﬁned as disease with surface involvement, ascites positive for
malignancy, or intra-operative tumor rupture. The majority of patients
underwent adjuvant chemotherapy with carboplatin and paclitaxel,
and 89.2% of patients received more than 3 cycles of chemotherapy.
No statistical signiﬁcance in survival was conferred in patients receiving
more than 3 cycles of chemotherapy at a given stage of disease. Interest-
ingly, survival for stage IA and IC intra-operative rupture only
disease was statistically similar. While the prognostic implications of
intra-operative tumor rupture remain unclear, less favorable patient
outcomes are seen when surface involvement or malignant ascites is
present when compared with intra-operative tumor rupture only, and
therefore adjuvant chemotherapy is recommended even in early stages
of disease (Shu et al., 2015).
This case is novel in that spontaneous rupture of a clear cell ovarian
tumor had occurred, and the patient presented with peritoneal signs
and an acute abdomen, which is a surgical emergency. Gynecologists
often see patients with ovarian malignancies presenting subacutely
with constitutional and abdominal and pelvic signs and symptoms in
an outpatient setting. However, epithelial ovarian carcinomas, and in
particular ovarian clear cell cancer, ought to remain in the differentialdiagnosis in patients presenting with an acute abdomen with imaging
suspicious for malignancy.
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